BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32660625)

  • 1. Screening strategies for adults with type 2 diabetes mellitus: a systematic review protocol.
    Mearns H; Otiku PK; Shelton M; Kredo T; Kagina BM; Schmidt BM
    Syst Rev; 2020 Jul; 9(1):156. PubMed ID: 32660625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of telemedicine diabetic retinopathy screening in the USA: a protocol for systematic review and meta-analysis.
    Padilla Conde T; Robinson L; Vora P; Ware SL; Stromberg A; Bastos de Carvalho A
    Syst Rev; 2023 Mar; 12(1):48. PubMed ID: 36927386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care.
    Pillay J; Rahman S; Klarenbach S; Reynolds DL; Tessier LA; Thériault G; Persaud N; Finley C; Leighl N; McInnes MDF; Garritty C; Traversy G; Tan M; Hartling L
    Syst Rev; 2024 Mar; 13(1):88. PubMed ID: 38493159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to increase attendance for diabetic retinopathy screening.
    Lawrenson JG; Graham-Rowe E; Lorencatto F; Burr J; Bunce C; Francis JJ; Aluko P; Rice S; Vale L; Peto T; Presseau J; Ivers N; Grimshaw JM
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012054. PubMed ID: 29333660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation-based education for teaching aggression management skills to health care providers in the acute health care setting: a systematic review protocol.
    Mitchell M; Bernie C; Newall F; Williams K
    Syst Rev; 2020 Sep; 9(1):208. PubMed ID: 32887661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
    Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis.
    Tricco AC; Ashoor HM; Soobiah C; Hemmelgarn B; Moher D; Hutton B; Yu CH; Majumdar SR; Straus SE
    Syst Rev; 2013 Sep; 2():73. PubMed ID: 24020869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis.
    Tricco AC; Antony J; Soobiah C; Hemmelgarn B; Moher D; Hutton B; Yu CH; Majumdar SR; Straus SE
    Syst Rev; 2013 Jun; 2():47. PubMed ID: 23810103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based care for the management of type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(23):1-40. PubMed ID: 23074528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.
    Konnyu KJ; Yogasingam S; Lépine J; Sullivan K; Alabousi M; Edwards A; Hillmer M; Karunananthan S; Lavis JN; Linklater S; Manns BJ; Moher D; Mortazhejri S; Nazarali S; Paprica PA; Ramsay T; Ryan PM; Sargious P; Shojania KG; Straus SE; Tonelli M; Tricco A; Vachon B; Yu CH; Zahradnik M; Trikalinos TA; Grimshaw JM; Ivers N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD014513. PubMed ID: 37254718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis.
    Hansen ML; Hyttel-Sørensen S; Jakobsen JC; Gluud C; Kooi EMW; Mintzer J; de Boode WP; Fumagalli M; Alarcon A; Alderliesten T; Greisen G
    Syst Rev; 2021 Apr; 10(1):111. PubMed ID: 33863369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.